Skip links

Author: oncologs.com

component-of-keto-diet-plus-immunotherapy-may-reduce-prostate-cancer

Component of keto diet plus immunotherapy may reduce prostate cancer

Adding a pre-ketone supplement — a component of a high-fat, low-carb ketogenic diet — to a type of cancer therapy in a laboratory setting was highly effective for treating prostate cancer, researchers from the University of Notre Dame found. Credit: Photo by Barbara Johnston/University of
md-anderson-and-rush-unveil-rush-md anderson-cancer-center

MD Anderson and RUSH unveil RUSH MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and RUSH University System for Health today announced a partnership to create RUSH MD Anderson Cancer Center. The partnership represents advanced clinical and operational integration in the delivery of cancer care, providing RUSH patients greater access to
experimental-nih-malaria-monoclonal-antibody-protective-in-malian-children

Experimental NIH malaria monoclonal antibody protective in Malian children

One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial. The trial assessed an investigational monoclonal antibody developed by scientists at
findings-of-large-scale-study-on-572-asian-families-supports-gene-directed-management-of-brca1-and-brca2-gene-carriers-in-singapore

Findings of large-scale study on 572 Asian families supports gene-directed management of BRCA1 and BRCA2 gene carriers in Singapore

Singapore, 26 April 2024 – A team of clinician-scientists and scientists from the University of Nottingham (Malaysia campus), National Cancer Centre Singapore (NCCS), Cancer Research Malaysia, Nanyang Technological University, Singapore (NTU Singapore), University of Malaya, University of Cambridge, A*STAR’s Genome Institute of Singapore (GIS) and other institutions,
$2.7-million-grant-to-explore-hypoxia’s-impact-on-blood-stem-cells

$2.7 million grant to explore hypoxia’s impact on blood stem cells

INDIANAPOLIS — Indiana University School of Medicine scientists are on a mission to understand why hematopoietic stem cells, responsible for producing all types of mature blood cells, exhibit better responses in a low-oxygen environment within the bone marrow, also known as hypoxia. Their discoveries and innovative approaches could influence treatment options like bone marrow transplantation for conditions such as bone marrow failure and rare blood diseases involving gene corrected stem cells. Credit: Indiana University School of Medicine INDIANAPOLIS — Indiana University School
a-shortcut-for-drug-discovery

A shortcut for drug discovery

For most human proteins, there are no small molecules known to bind them chemically (so called “ligands”). Ligands frequently represent important starting points for drug development but this knowledge gap critically hampers the development of novel medicines. Researchers at CeMM, in a collaboration with Pfizer,
insilico-medicine-receives-ind-approval-from-fda-for-novel-mat2a-inhibitor-ism3412

Insilico Medicine receives IND approval from FDA for novel MAT2A inhibitor ISM3412

Clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine (“Insilico”) announces that it has received approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for ISM3412, a small molecule inhibitor of MAT2A for the potential treatment of
Explore
Drag